COMMUNIQUÉS West-GlobeNewswire

Cerner Announces Amendment to Share Repurchase Program

21/05/2018 - 15:00

KANSAS CITY, Mo., May 21, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced that its board of directors approved an amendment to its stock repurchase program on May 17, 2018, at its regularly [...]

Letter to Shareholders from ACOL CEO Curt Fairbrother: May 21, 2018

21/05/2018 - 14:30

CORONA, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Dear Shareholders: Many of you have been following our company since its inception in 2013 and have seen the steady growth that we have achieved in that time. Our most [...]

NuvusGro (NUVG) Introduces the Nuvus Mobile Mining Unit (MoMu) Utilizing its Grow.Droid Enterprise Technology – MoMu to Mine Bitcoin, Ether, BCH, and Altcoins

21/05/2018 - 14:30

Saint Petersburg, FL, May 21, 2018 (GLOBE NEWSWIRE) -- NuvusGro Corp. (OTC PINK: NUVG), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]

Stanford Researchers Presented Results from an Exploratory Study of Serlopitant for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients Indicating Reduction in Itch with Serlopitant Treatment

21/05/2018 - 14:30

Results Presented at the International Investigative Dermatology Meeting REDWOOD CITY, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on [...]

Terveystalo Plc: Managers' Transactions

21/05/2018 - 14:16

TERVEYSTALO PLC MANAGERS' TRANSACTIONS 21 May 2018 at 15:15 EEST ____________________________________________ Person subject to the notification requirement Name: HC TT Holding Oy Ab (Hartwall Capital) Position: Closely [...]

Allscripts closes acquisition of HealthGrid

21/05/2018 - 14:01

Company expands its FollowMyHealth® consumer engagement platform with advanced capabilities CHICAGO, May 21, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ), a global leader in healthcare technology, today announces [...]

Terveystalo Plc: Managers' Transactions

21/05/2018 - 14:00

TERVEYSTALO PLC MANAGERS' TRANSACTIONS 21 May 2018 at 15:00 EEST ____________________________________________ Person subject to the notification requirement Name: Heinonen, Lasse Position: Member of the Board/Deputy [...]

MimiVax Announces Positive Interim Results from Phase II Trial of SurVaxM Immunotherapy for the Treatment of Newly Diagnosed Glioblastoma

21/05/2018 - 14:00

Interim analysis shows significant survival benefit compared to historical standard of care; Combination of SurVaxM and standard therapy was well-tolerated, with few serious side effects; MimiVax to share findings at [...]

Athenex to Present at UBS Global Healthcare Conference

21/05/2018 - 14:00

BUFFALO, N.Y., May 21, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the American Association of Critical-Care Nurses Exposition May 22-24

21/05/2018 - 14:00

Caregiver does not come into contact with the patient’s skin nor require probe covers, reducing the risk of cross-contamination and eliminating unnecessary costs DELRAY BEACH, Fla., May 21, 2018 (GLOBE NEWSWIRE) -- [...]

Immunomedics Submits Biologics License Application For Sacituzumab Govitecan To The U.S. Food and Drug Administration

21/05/2018 - 14:00

First-in-Class Antibody-Drug Conjugate had Received Prior Breakthrough Therapy Designation from the FDA for the Treatment of Metastatic Triple-Negative Breast Cancer MORRIS PLAINS, N.J., May 21, 2018 (GLOBE NEWSWIRE [...]

CLS Holdings USA Expects to Close its Acquisition of Oasis Cannabis by the End of the Second Quarter

21/05/2018 - 14:00

LAS VEGAS, May 21, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a development stage diversified cannabis company operating as Cannabis Life Sciences, today announced that its proposed acquisition [...]

Inovio Opens Phase 2 Trial for VGX-3100 in Third Indication To Treat HPV – The No. 1 Sexually Transmitted Disease

21/05/2018 - 14:00

Inovio initiates Phase 2 trial for HPV-related anal precancer; already advancing treatment for HPV-caused cervical precancers (Phase 3), and vulvar precancers (Phase 2) PLYMOUTH MEETING, Pa., May 21, 2018 (GLOBE [...]

Akari Therapeutics Receives Notice Related to Delay in 20-F Filing

21/05/2018 - 14:00

NEW YORK and LONDON, May 21, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan [...]

Cidara Therapeutics Announces Offering of Common Stock and Warrants

21/05/2018 - 13:30

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has entered into a [...]

MyoKardia Announces Design of Phase 3 EXPLORER-HCM Study Evaluating Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy

21/05/2018 - 13:30

Single Pivotal to Support Registration; Target Enrollment of 220 Patients; Primary Endpoint of Clinical Response Using Peak VO 2 and NYHA Classification Improvements Expected to Initiate in Second Quarter 2018; Topline [...]

Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia

21/05/2018 - 13:30

- Lefamulin met all FDA and EMA primary endpoints and was shown to be generally well tolerated - - Company plans to file a New Drug Application with the U.S. Food and Drug Administration in the fourth quarter of 2018 [...]

Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study

21/05/2018 - 13:01

Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study - Primary endpoint met with highly [...]

AxoGen, Inc. Announces Appointment of Karen Zaderej as Chairman of the Board

21/05/2018 - 13:01

ALACHUA, Fla., May 21, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that its Board of Directors [...]